0000950170-24-131590.txt : 20241127 0000950170-24-131590.hdr.sgml : 20241127 20241127170003 ACCESSION NUMBER: 0000950170-24-131590 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241125 FILED AS OF DATE: 20241127 DATE AS OF CHANGE: 20241127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xie Jian CENTRAL INDEX KEY: 0001819718 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 241512174 MAIL ADDRESS: STREET 1: C/O FULGENT GENETICS, INC. STREET 2: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 ownership.xml 4 X0508 4 2024-11-25 false 0001674930 Fulgent Genetics, Inc. FLGT 0001819718 Xie Jian C/O FULGENT GENETICS, INC. 4399 SANTA ANITA AVENUE EL MONTE CA 91731 false true false false President and COO false Common Stock 2024-11-25 4 S false 689 18.2593 D 336136 D Common Stock 220816 I By Trust The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. The shares were sold in multiple transactions at prices ranging from $18.12 to $18.50, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein. /s/ Paul Kim as Attorney-in-Fact 2024-11-27